Stock Information
SHARE PRICE: $0.279
VOLUME: 12,291
MARKET CAP: $12,127,628.00
SHARE COUNT: 43,468,200
DAILY HIGH: $0.25
DAILY LOW: $0.241
OPEN: $0.241
CLOSE: $0.0000
PREV. CLOSE: $0.0000
CHANGE: $0.0000 (0%)
52-WEEK HIGH: $0.8401
52-WEEK LOW: $0.0008
LAST UPDATED: 10 hours ago
NEW YORK, NY / ACCESSWIRE / December 19, 2024 /Cell Source, Inc. (OTCQB:CLCS) ("Cell Source" or the "Company"), a leading innovator in immune tolerance management, recently presented promising preclinical findings at the 2024 American Society of Hematology ...
First-of-Its-Kind Success in Mismatched Donor Stem Cell Transplantation: Engraftment Under Mild Immune Suppression with Minimal Graft-versus-Host Disease NEW YORK, NY / ACCESSWIRE / November 21, 2024 /Cell Source, Inc. (OTCQB:CLCS) ("Cell Source", ...
Investor Relations Contact
Cell Source, Inc.
57 West 57th Street, Suite 400
New York, NY 10019
+1 646 416-7896 Phone
+1 646 416-8001 Fax
Email: info@cell-source.com
Securities Counsel
Giordano Halleran & Ciesla
Philip D. Forlenza, Esq.
125 Half Mile Road, Suite 300
Red Bank, NJ 07701-6777
Phone: 732-741-3900
Email: PForlenza@ghclaw.com
WWW: www.ghclaw.com
Independent Auditor
Marcum LLP
750 Third Ave, 11th Floor
New York, NY 10017